Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15-80
SponsorThe First Affiliated Hospital of Soochow University
About this trial
The main objectives of this study were :(1) to comprehensively and systematically evaluate the nutritional status of patients after hematopoietic stem cell transplantation. (2) to explore the effect of nutritional factors on the prognosis of patients treated by hematopoietic stem cell transplantation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who undergo hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University.
Having a life expectancy of more than 3 months
Disqualifiers
Not willing to participate in the investigation
Age less than 15 years old or more than 80 years old
Trial population
Patients who have received hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
not have
Other interventionnot have
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Change from Baseline fat free mass at 6 months
Body composition analyzer INBO DY S10 (bioelectrical impedance method) is used to analyze the content of fat free mass（ kilograms）
Time frame
6 months2
Change from Baseline fat mass at 6 months
Body composition analyzer INBODY S10 (bioelectrical impedance method) is used to analyze the content of fat mass（ kilograms）
Time frame
6 months3
Change from Baseline food intake at 6 months
24-hour dietary record and semi-quantitative food frequency questionnaire are used to evaluate the eating condition of patients
Time frame
6 months4
Change from Baseline albumin level in blood at 6 months
The content of albumin in blood is determined.
Time frame
6 monthsSecondary outcomes
1
Overall survial
It is measured from the date of entry into this trial to the date of death from any cause; patients not known to have died at last follow-up are censored on the date they were last known to be alive
Time frame
3 years2
Event free survival
It is measured from the date of entry into this trial to the date of relapse from CR, or CRi, or death from any cause; patients not known to have any of these events are censored on the date they were last examined.
Time frame
3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov